NMNAT3 Human Pre-designed siRNA Set A contains three designed siRNAs for NMNAT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMRAL1 Human Pre-designed siRNA Set A contains three designed siRNAs for NMRAL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMRK1 Human Pre-designed siRNA Set A contains three designed siRNAs for NMRK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMRK2 Human Pre-designed siRNA Set A contains three designed siRNAs for NMRK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMS Human Pre-designed siRNA Set A contains three designed siRNAs for NMS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMS-0963 (compound 1) is an inhibitor of spleen tyrosine kinase (SYK) with an oral activity and IC50 value of 3 nM. NMS-0963 inhibits BaF3-TEL/SYK cell line proliferative at 27 nM[1].

NMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for NMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for NMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMU Human Pre-designed siRNA Set A contains three designed siRNAs for NMU gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMUR1 Human Pre-designed siRNA Set A contains three designed siRNAs for NMUR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMUR2 Human Pre-designed siRNA Set A contains three designed siRNAs for NMUR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NMY1009 is a lipophilic C8-hydrocarbon chain conjugated analog that links mitochondrial uncouplers via ether linkages. NMY1009 can be released and enter the mitochondrial matrix and intermembrane space, thereby targeting mitochondrial uncoupler to adipose tissue and increasing energy expenditure in brown and white adipose tissue[1].

NNAT Human Pre-designed siRNA Set A contains three designed siRNAs for NNAT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NNMT Human Pre-designed siRNA Set A contains three designed siRNAs for NNMT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NNMT-IN-5 (Compound 3-12) is a potent nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 47.9 ± 0.6 nM). NNMT-IN-5 also has an excellent selectivity profile over a panel of human methyltransferases. NNMT-IN-5 can be used for the research of cancer, diabetes, metabolic disorders, and neurodegenerative diseases[1].

NNT Human Pre-designed siRNA Set A contains three designed siRNAs for NNT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NO-711ME is a prodrug of NO-711. NO-711 is a potent and selective GABA uptake inhibitor[1].

NO-Losartan A (compound 2a) displays vasorelaxing effects, due to the release of NO, and antagonized the vasocontractile effects of Angiotensin II (HY-13948), with potency values similar to that of Losartan (HY-17512)[1].

NO2A-(t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. NO2A-(t-Bu ester) can be used for conjugation of peptides and radionuclides.

NO2A-Azide (trihydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. NO2A-Azide (trihydrochloride) can be used for conjugation of peptides and radionuclides.

NO2A-Butyneis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. NO2A-Butyne can be used for conjugation of peptides and radionuclides.

NO2A-Butyne-bis(t-Butyl ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. NO2A-Butyne-bis(t-Butyl ester) can be used for conjugation of peptides and radionuclides.

NOA1 Human Pre-designed siRNA Set A contains three designed siRNAs for NOA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOB1 Human Pre-designed siRNA Set A contains three designed siRNAs for NOB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOBOX Human Pre-designed siRNA Set A contains three designed siRNAs for NOBOX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOC2L Human Pre-designed siRNA Set A contains three designed siRNAs for NOC2L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOC3L Human Pre-designed siRNA Set A contains three designed siRNAs for NOC3L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOCT Human Pre-designed siRNA Set A contains three designed siRNAs for NOCT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOD1 Human Pre-designed siRNA Set A contains three designed siRNAs for NOD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nod1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nod1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nod1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nod1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOD2 Human Pre-designed siRNA Set A contains three designed siRNAs for NOD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nod2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nod2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nod2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nod2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NODAL Human Pre-designed siRNA Set A contains three designed siRNAs for NODAL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOG Human Pre-designed siRNA Set A contains three designed siRNAs for NOG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL10 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL11 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL12 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL3 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL4 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL6 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL7 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL8 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOL9 Human Pre-designed siRNA Set A contains three designed siRNAs for NOL9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.